Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients

Antifungal Agents Clinical Trial

Official title:
(1-3)-Beta-D-Glucan Driven vs. Empirical Antifungal Therapy in High Risk Critically Ill Patients A Randomized Study

Status Completed

Clinical Trial Summary

This study is aimed to compare the duration of standard anti fungal therapy in high risk ICU patients with a strategy driven by BetaDGlucan test result

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03117439
Study type	Interventional
Source	Policlinico Universitario Agostino Gemelli
Contact
Status	Completed
Phase	N/A
Start date	July 2016
Completion date	August 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04157465` - Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients	N/A
Recruiting	`NCT03136926` - Screening Anti-Fungal Exposure in Intensive Care Units
Completed	`NCT04318535` - Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions	Phase 1
Enrolling by invitation	`NCT06178627` - Amphotericin B for Non-HIV Cryptococcal Meningitis Patients	Phase 4